MDXH stock news · MDxHealth SA
Get alerts for MDXH
Follow MDxHealth SA (MDXH) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MDXHAn Ameriprise Financial expert is now less optimistic; check out the 5 companies they downgraded on Monday.
Bad for MDXHMDxHealth's analyst moved its rating from Buy to Neutral. That signals less confidence in the company, and the article gives no positive company news to balance it.
12 health care stocks are changing a lot during Friday's trading.
NeutralMDxHealth shares fell 63.5% to $0.22, but the article gives no business news behind the move. It does not change the company's outlook.
12 health care stocks are changing a lot before the market opens on Friday.
NeutralMDxHealth shares fell 23.03%. The article gives no company news, so this does not change its business outlook.
12 health care stocks changed a lot in prices during Thursday's after-hours trading.
NeutralMDxHealth shares fell 11.4% after hours. The article gives no company update or reason, so this move alone does not change its business outlook.
12 health care companies saw big changes in their stock prices after the market closed on Wednesday.
NeutralMDxHealth shares fell 6.64% to $0.56 after hours, but the roundup gives no company news, so its business outlook is unchanged.
12 health care companies are seeing big changes in their stock prices today.
NeutralMDxHealth shares rose 16% to $0.61. The article gives no company news explaining the move, so it does not change the business outlook.
MDxHealth asserts strong readiness to achieve positive EBITDA once again.
NeutralMDxHealth's stock surged following the release of its quarterly earnings report, which showed a revenue increase and a commitment to return to positive EBITDA. The company's strategic focus on its core prostate cancer business and positive test volume trends further bolster investor confidence.
MDxHealth Q2 2026 Earnings Call Complete Transcript Released.
NeutralMDxHealth's Q2 2026 earnings call revealed a strong revenue increase and operational improvements, including the elimination of a significant liability. This positive performance and management's confidence in future guidance could lead to increased investor interest and stock movement.